{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T14:02:48Z","timestamp":1771855368847,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,11,11]],"date-time":"2020-11-11T00:00:00Z","timestamp":1605052800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,11]],"date-time":"2020-11-11T00:00:00Z","timestamp":1605052800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","award":["2018YFC1312303, 2016YFC1301604, 2018YFC1705003"],"award-info":[{"award-number":["2018YFC1312303, 2016YFC1301604, 2018YFC1705003"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","award":["2018YFC2002302"],"award-info":[{"award-number":["2018YFC2002302"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s10072-020-04881-w","type":"journal-article","created":{"date-parts":[[2020,11,11]],"date-time":"2020-11-11T21:07:28Z","timestamp":1605128848000},"page":"2829-2835","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Effect of prediabetes on asprin or clopidogrel resistance in patients with recent ischemic stroke\/TIA"],"prefix":"10.1007","volume":"42","author":[{"given":"Weili","family":"Jia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3417-4880","authenticated-orcid":false,"given":"Qian","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingquan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongjun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,11,11]]},"reference":[{"issue":"2","key":"4881_CR1","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s10072-015-2412-x","volume":"37","author":"G Cai","year":"2016","unstructured":"Cai G, Zhou W, Lu Y, Chen P, Lu Z, Fu Y (2016) Aspirin resistance and other aspirin-related concerns. Neurol Sci 37(2):181\u2013189. https:\/\/doi.org\/10.1007\/s10072-015-2412-x","journal-title":"Neurol Sci"},{"issue":"3\u20134","key":"4881_CR2","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1159\/000438722","volume":"74","author":"C Coignion","year":"2015","unstructured":"Coignion C, Poli M, Sagnier S, Freyburger G, Renou P, Debruxelles S, Rouanet F, Sibon I (2015) Interest of antiplatelet drug testing after an acute ischemic stroke. Eur Neurol 74(3\u20134):135\u2013139. https:\/\/doi.org\/10.1159\/000438722","journal-title":"Eur Neurol"},{"key":"4881_CR3","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1111\/j.1747-4949.2012.00929.x","volume":"8","author":"X Yi","year":"2013","unstructured":"Yi X, Zhou Q, Lin J, Chi L (2013a) Aspirin resistance in Chinese stroke patients increased the rate of recurrent stroke and other vascular events. International Journal of Stroke: official Journal of the International Stroke Society 8:535\u2013539. https:\/\/doi.org\/10.1111\/j.1747-4949.2012.00929.x","journal-title":"International Journal of Stroke: official Journal of the International Stroke Society"},{"key":"4881_CR4","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.prostaglandins.2015.03.011","volume":"120","author":"CN Floyd","year":"2015","unstructured":"Floyd CN, Ferro A (2015) Antiplatelet drug resistance: molecular insights and clinical implications. Prostaglandins Other Lipid Mediat 120:21\u201327. https:\/\/doi.org\/10.1016\/j.prostaglandins.2015.03.011","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"4881_CR5","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.jacc.2010.04.047","volume":"56","author":"B Laurent","year":"2010","unstructured":"Laurent B, Udaya ST, Rossella M, Ruediger B, Dominick JA, Richard B, Deepak LB, Marco C, Jean PC, Thomas C, Christian G, Gilles M, Lisa KJ, Dean K, Dirk S, Dietmar T, Jochem WVW, Franck P, Matthew JP, Ron W, Paul AG (2010) Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate. J Am Coll Cardiol 56:919\u2013933. https:\/\/doi.org\/10.1016\/j.jacc.2010.04.047","journal-title":"J Am Coll Cardiol"},{"key":"4881_CR6","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jns.2017.03.010","volume":"376","author":"A Fiolaki","year":"2017","unstructured":"Fiolaki A, Katsanos AH, Kyritsis AP, Papadaki S, Kosmidou M, Moschonas IC, Tselepis AD, Giannopoulos S (2017) High on treatment platelet reactivity to aspirin and clopidogrel in ischemic stroke: a systematic review and meta-analysis. J Neurol Sci 376:112\u2013116. https:\/\/doi.org\/10.1016\/j.jns.2017.03.010","journal-title":"J Neurol Sci"},{"issue":"1","key":"4881_CR7","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1159\/000371793","volume":"131","author":"W Kuliczkowski","year":"2015","unstructured":"Kuliczkowski W, Gasior M, Pres D, Kaczmarski J, Laszowska A, Szewczyk M, Hawranek M, Tajstra M, Zeglen S, Polonski L, Serebruany VL (2015) Aspirin \u2018resistance\u2019: impact on no-reflow, platelet and inflammatory biomarkers in diabetics after ST-segment elevation myocardial infarction. Cardiology 131(1):41\u201350. https:\/\/doi.org\/10.1159\/000371793","journal-title":"Cardiology"},{"issue":"8","key":"4881_CR8","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1007\/s00415-016-8181-5","volume":"263","author":"XY Yi","year":"2016","unstructured":"Yi XY, Wang C, Liu P, Fu C, Lin J, Chen YM (2016) Antiplatelet drug resistance is associated with early neurological deterioration in acute minor ischemic stroke in the Chinese population. J Neurol 263(8):1612\u20131619. https:\/\/doi.org\/10.1007\/s00415-016-8181-5","journal-title":"J Neurol"},{"issue":"5","key":"4881_CR9","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1161\/Strokeaha.113.002977","volume":"45","author":"Q Jia","year":"2014","unstructured":"Jia Q, Liu GF, Zheng HG, Zhao XQ, Wang CX, Wang YL, Liu LP, Wang YJ, Gluc ISA (2014) Impaired glucose regulation predicted 1-year mortality of Chinese patients with ischemic stroke data from abnormal glucose regulation in patients with acute stroke across China. Stroke 45(5):1498\u20131500. https:\/\/doi.org\/10.1161\/Strokeaha.113.002977","journal-title":"Stroke"},{"issue":"10","key":"4881_CR10","doi-asserted-by":"publisher","first-page":"2758","DOI":"10.1161\/Strokeaha.111.621649","volume":"42","author":"Q Jia","year":"2011","unstructured":"Jia Q, Zhao XQ, Wang CX, Wang YL, Yan Y, Li H, Zhong LY, Liu LP, Zheng HG, Zhou Y, Wang YJ (2011) Diabetes and poor outcomes within 6 months after acute ischemic stroke the China National Stroke Registry. Stroke 42(10):2758\u20132762. https:\/\/doi.org\/10.1161\/Strokeaha.111.621649","journal-title":"Stroke"},{"issue":"4","key":"4881_CR11","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1161\/Strokeaha.116.015613","volume":"48","author":"J Jing","year":"2017","unstructured":"Jing J, Pan YS, Zhao XQ, Zheng HG, Jia Q, Mi DH, Chen WQ, Li H, Liu LP, Wang CX, He Y, Wang D, Wang YL, Wang YJ, I. ACROSS-China (2017) Insulin resistance and prognosis of nondiabetic patients with ischemic stroke the ACROSS-China study (abnormal glucose regulation in patients with acute stroke across China). Stroke 48(4):887\u2013893. https:\/\/doi.org\/10.1161\/Strokeaha.116.015613","journal-title":"Stroke"},{"issue":"1","key":"4881_CR12","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1161\/CIRCULATIONAHA.116.024913","volume":"135","author":"Y Pan","year":"2017","unstructured":"Pan Y, Chen W, Xu Y, Yi X, Han Y, Yang Q, Li X, Huang L, Johnston SC, Zhao X, Liu L, Zhang Q, Wang G, Wang Y, Wang Y (2017a) Genetic polymorphisms and clopidogrel efficacy for acute ischemic stroke or transient ischemic attack: a systematic review and meta-analysis. Circulation 135(1):21\u201333. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.116.024913","journal-title":"Circulation"},{"issue":"1","key":"4881_CR13","doi-asserted-by":"publisher","first-page":"ARTN e004990","DOI":"10.1161\/JAHA.116.004990","volume":"6","author":"YS Pan","year":"2017","unstructured":"Pan YS, Jing J, Chen WQ, Zheng HG, Jia Q, Mi DH, Li H, Zhao XQ, Liu LP, Wang CX, Gaisano HY, He Y, Wang YL, Wang YJ (2017b) Post-glucose load measures of insulin resistance and prognosis of nondiabetic patients with ischemic stroke. J Am Heart Assoc 6(1):ARTN e004990. https:\/\/doi.org\/10.1161\/JAHA.116.004990","journal-title":"J Am Heart Assoc"},{"key":"4881_CR14","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/978-1-62703-339-8_17","volume":"992","author":"JP Frontroth","year":"2013","unstructured":"Frontroth JP (2013) Light transmission aggregometry. Methods Mol Biol 992:227\u2013240. https:\/\/doi.org\/10.1007\/978-1-62703-339-8_17","journal-title":"Methods Mol Biol"},{"key":"4881_CR15","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/978-1-4939-7196-1_25","volume":"1646","author":"AM Hvas","year":"2017","unstructured":"Hvas AM, Favaloro EJ (2017) Platelet function analyzed by light transmission aggregometry. Methods Mol Biol 1646:321\u2013331. https:\/\/doi.org\/10.1007\/978-1-4939-7196-1_25","journal-title":"Methods Mol Biol"},{"key":"4881_CR16","doi-asserted-by":"publisher","first-page":"531","DOI":"10.11909\/j.issn.1671-5411.2016.06.009","volume":"13","author":"L Liu","year":"2016","unstructured":"Liu L, Gao YH, Cao J, Zhang HX, Fan L, Hu GL (2016) High prevalence of aspirin resistance in elderly patients with cardiovascular disease and metabolic syndrome. Journal of geriatric cardiology: JGC 13:531\u2013536. https:\/\/doi.org\/10.11909\/j.issn.1671-5411.2016.06.009","journal-title":"Journal of geriatric cardiology: JGC"},{"issue":"2","key":"4881_CR17","doi-asserted-by":"publisher","first-page":"e133","DOI":"10.1097\/MJT.0000000000001099","volume":"27","author":"E Bobescu","year":"2020","unstructured":"Bobescu E, Covaciu A, Rus H, Rogozea LM, Badea M, Marceanu LG (2020) Low response to clopidogrel in coronary artery disease. Am J Ther 27(2):e133\u2013e141. https:\/\/doi.org\/10.1097\/MJT.0000000000001099","journal-title":"Am J Ther"},{"key":"4881_CR18","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2147\/VHRM.S28090","volume":"8","author":"RK Sharma","year":"2012","unstructured":"Sharma RK, Voelker DJ, Sharma R (2012) Evolving role of platelet function testing in coronary artery interventions. Vasc Health Risk Manag 8:65\u201375. https:\/\/doi.org\/10.2147\/VHRM.S28090","journal-title":"Vasc Health Risk Manag"},{"issue":"1","key":"4881_CR19","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1001\/jama.2016.8662","volume":"316","author":"Y Wang","year":"2016","unstructured":"Wang Y, Zhao X, Lin J, Li H, Johnston SC, Lin Y, Pan Y, Liu L, Wang D, Wang C, Meng X, Xu J, Wang Y, C. investigators (2016) Association between CYP2C19 loss-of-function allele status and efficacy of clopidogrel for risk reduction among patients with minor stroke or transient ischemic attack. JAMA 316(1):70\u201378. https:\/\/doi.org\/10.1001\/jama.2016.8662","journal-title":"JAMA"},{"issue":"2","key":"4881_CR20","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3109\/09537104.2013.777951","volume":"25","author":"A Lundstrom","year":"2014","unstructured":"Lundstrom A, Laska AC, Von Arbin M, Jorneskog G, Wallen H (2014) Glucose intolerance and insulin resistance as predictors of low platelet response to clopidogrel in patients with minor ischemic stroke or TIA. Platelets 25(2):102\u2013110. https:\/\/doi.org\/10.3109\/09537104.2013.777951","journal-title":"Platelets"},{"issue":"2","key":"4881_CR21","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/s11239-015-1177-7","volume":"40","author":"U Masafumi","year":"2015","unstructured":"Masafumi U, Kosuke F, Hiroyuki Y, Tomoyuki I, Tatsuya S, Kenji Y, Shinichiro I, Kazuhiro K, Yoshitaka I, Dominick JA, Shunichi M (2015) Impact of impaired glucose tolerance on clopidogrel response in patients with coronary artery disease. J Thromb Thrombolysis 40(2):174\u2013181. https:\/\/doi.org\/10.1007\/s11239-015-1177-7","journal-title":"J Thromb Thrombolysis"},{"issue":"2","key":"4881_CR22","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1161\/01.ATV.0000199519.37089.a0","volume":"26","author":"IA Ferreira","year":"2006","unstructured":"Ferreira IA, Mocking AIM, Feijge MAH, Gorter G, van Haeften TW, Heemskerk JWM, Akkerman JWN (2006) Platelet inhibition by insulin is absent in type 2 diabetes mellitus. Arterioscler Thromb Vasc Biol 26(2):417\u2013422. https:\/\/doi.org\/10.1161\/01.ATV.0000199519.37089.a0","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"4881_CR23","doi-asserted-by":"publisher","first-page":"742719","DOI":"10.1155\/2011\/742719","volume":"2011","author":"N Kakouros","year":"2011","unstructured":"Kakouros N, Rade JJ, Kourliouros A, Resar JR (2011) Platelet function in patients with diabetes mellitus: from a theoretical to a practical perspective. Int J Endocrinol 2011:742719. https:\/\/doi.org\/10.1155\/2011\/742719","journal-title":"Int J Endocrinol"},{"issue":"1","key":"4881_CR24","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jdiacomp.2007.06.003","volume":"23","author":"A Le Guyader","year":"2009","unstructured":"Le Guyader A, Pacheco G, Seaver N, Davis-Gorman G, Copeland J, McDonagh PF (2009) Inhibition of platelet GPIIb-IIIa and P-selectin expression by aspirin is impaired by stress hyperglycemia. J Diabetes Complicat 23(1):65\u201370. https:\/\/doi.org\/10.1016\/j.jdiacomp.2007.06.003","journal-title":"J Diabetes Complicat"},{"issue":"11","key":"4881_CR25","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.2337\/db12-0040","volume":"61","author":"I Russo","year":"2012","unstructured":"Russo I, Viretto M, Barale C, Mattiello L, Doronzo G, Pagliarino A, Cavalot F, Trovati M, Anfossi G (2012) High glucose inhibits the aspirin-induced activation of the nitric oxide\/cGMP\/cGMP-dependent protein kinase pathway and does not affect the aspirin-induced inhibition of thromboxane synthesis in human platelets. Diabetes 61(11):2913\u20132921. https:\/\/doi.org\/10.2337\/db12-0040","journal-title":"Diabetes"},{"key":"4881_CR26","doi-asserted-by":"publisher","unstructured":"Stroke 1989. Recommendations on stroke prevention, diagnosis, and therapy. Report of the WHO Task Force on stroke and other cerebrovascular disorders. Stroke 20(10): 1407\u20131431. https:\/\/doi.org\/10.1161\/01.str.20.10.1407","DOI":"10.1161\/01.str.20.10.1407"},{"issue":"6","key":"4881_CR27","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/bcpt.12840","volume":"121","author":"SW Al-Jabi","year":"2017","unstructured":"Al-Jabi SW (2017) Global trends in aspirin resistance-related research from 1990 to 2015: a bibliometric analysis. Basic Clin Pharmacol Toxicol 121(6):512\u2013519. https:\/\/doi.org\/10.1111\/bcpt.12840","journal-title":"Basic Clin Pharmacol Toxicol"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-020-04881-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-020-04881-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-020-04881-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T08:12:23Z","timestamp":1625645543000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-020-04881-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,11]]},"references-count":27,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["4881"],"URL":"https:\/\/doi.org\/10.1007\/s10072-020-04881-w","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,11]]},"assertion":[{"value":"29 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest pertaining to this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This retrospective chart review study involving human participants was in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The Human Investigation Committee (IRB) of the Ethics Committee at Beijing Tiantan Hospital approved this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}